Trial Profile
Clinical Pharmacology Study of TS-071 in Paediatric Patients with Type 2 Diabetes Mellitus
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Taisho Pharmaceutical
- 30 Nov 2018 Status changed from not yet recruiting to recruiting.
- 24 Jul 2018 New trial record